Teriparatide for Osteoporosis: A Clinical Review

P and T

Volumn 28, Issue 11, 2003, Pages 713-716

  Honeywell, Marlon ^a   Phillips, Shay ^b   Branch III, Evans ^a   Vo, Kim Anh ^c   Marks, Eardie I ^a   Thompson, Michael ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

^b HAMPTON UNIVERSITY   (United States)

^c Florida A and M University ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; DIGOXIN; ESTROGEN; GESTAGEN; HYDROCHLOROTHIAZIDE; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; RISEDRONIC ACID; SALCATONIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

ANGINA PECTORIS; ASTHENIA; BACKACHE; BONE DENSITY; BONE MASS; BONE MINERAL; BONE STRENGTH; CLINICAL TRIAL; CONSTIPATION; DEPRESSION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENTIATION; DRUG PULSE THERAPY; HEADACHE; HUMAN; HYPERCALCEMIA; HYPERTENSION; HYPERURICEMIA; INSOMNIA; LEG CRAMP; NAUSEA; NECK PAIN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; OSTEOSARCOMA; PAGET BONE DISEASE; PREVALENCE; REVIEW; SEX DIFFERENCE; SYNCOPE; VERTIGO;

EID: 0345564958     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Kenny A, Prestwood K. Osteoporosis: Pathogenesis, diagnosis, and treatment in older adults. Rheum Dis Clin North Am 2000;26(3):569-591.
2. National Osteoporosis Foundation. Available at: www.nof.org/osteoporosis.html. Accessed March 11, 2003.
3. CenterWatch: Clinical Trials Listing Service. Drugs Approved by the FDA. Available at: www.centerwatch.com/patient/drugs/dru812.html. Accessed March 9, 2003.
4. Body JJ, Gaich GA, Scheele WH, et al. A randomized, double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 2002;87(10):4528-4535.
5. Suzuki Y, Nagase Y, Iga K, et al. Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH (1-34). J Pharm Sci 2002;91(2):350-361.
6. Food and Drug Administration. Blackbox warning: Teriparatide injection. Available at: www.fda,gov. Accessed August 25, 2003.
7. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344(19):1434-1440.
8. Forteo® (teriparatide injection) package insert. Indianapolis, IN: Eli Lilly and Company; November 2002.
9. Teriparatide (rDNA origin) 003579. Mosby's Drug Consult: Drug Updates. Available at: www.mosbysdrugconsult. com. Accessed March 9, 2003.
10. Horwitz M, Tedesco M, Gundberg C, et al. Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 2003;88:569-575.
11. Kurland E, Cosman F, McMahon D, et al. Parathyroid hormone as a therapy for idiopathic osteoporosis in men. J Clin Endocrinol Metab 2000;85:3069-3076.
12. Rittmaster R, Bolognese M, Ettinger M, et al. Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. J Clin Endocrinol Metab 2000;85:2129-2134.
13. Finklestein JS, Klibanski A, Arnold AL, et al. Prevention of estrogen deficiency related bone loss with human parathyroid hormone (1-34). JAMA 1998;280:1067-1073.
14. Okimoto N, Tsurukami H, Okazaki, et al. Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats. Bone 1998;22(5):523-531.
15. Kneissel M, Boyde A, Gasser J. Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH (1-34). Bone 2001;28(3):237-250.
16. Abramowicz M, Zuccotti G, Rizack MA, et al. Teriparatide (Forteo) for osteoporosis. Medical Lett Drugs Ther 2003;45(1149):9-10.
17. Skriptiz R, Andreassen TT, Aspenberg P. Strong effect of PTH (1-34) on regenerating bone. Acta Orthop Scand 2000;71:619-624.